BioStem Technologies, Inc. (BSEM)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$4.14+$0.2600 (+6.70%) on the dayAs of the close; data may be delayed.
BSEM price, last 12 months
Key stats
- Previous close
- $3.88
- Open
- $3.85
- Day range
- $3.81 – $4.28
- 52-week range
- $2.25 – $8.40
- Volume
- 278.9K
- Avg volume (20 days)
- 176.4K
- Market cap
- $74.3M
Performance
1W−12.7%
1M+13.1%
3M+15.5%
6M−17.0%
YTD+8.7%
1Y−18.7%
vs S&P 500, 1Y−35.4 pts
Technicals and fundamentals
About BioStem Technologies, Inc.
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $74.3M